Table of Contents Author Guidelines Submit a Manuscript
Journal of Skin Cancer
Volume 2012, Article ID 410925, 8 pages
http://dx.doi.org/10.1155/2012/410925
Research Article

Ultraviolet Radiation and the Slug Transcription Factor Induce Proinflammatory and Immunomodulatory Mediator Expression in Melanocytes

1Department of Molecular Carcinogenesis, Science Park, The University of Texas MD Anderson Cancer Center, 1808 Park Road 1C, Smithville, TX 78957, USA
2Melanoma Medical Oncology Department, Unit 0362, The University of Texas MD Anderson Cancer Center, Anderson Central (Y8.5325), 1515 Holcombe Boulevard, Houston, TX 77030, USA

Received 6 February 2012; Accepted 30 March 2012

Academic Editor: B. G. Redman

Copyright © 2012 Stephanie H. Shirley et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. Leiter and C. Garbe, “Epidemiology of melanoma and nonmelanoma skin cancer—the role of sunlight,” Advances in Experimental Medicine and Biology, vol. 624, pp. 89–103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Jhappan, F. P. Noonan, and G. Merlino, “Ultraviolet radiation and cutaneous malignant melanoma,” Oncogene, vol. 22, no. 20, pp. 3099–3112, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Moan, A. C. Porojnicu, and A. Dahlback, “Ultraviolet radiation and malignant melanoma,” Advances in Experimental Medicine and Biology, vol. 624, pp. 104–116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. E. Kanavy and M. R. Gerstenblith, “Ultraviolet radiation and melanoma,” Seminars in Cutananeous Medicine and Surgery, vol. 30, no. 4, pp. 222–228, 2011. View at Google Scholar
  5. T. Hocker and H. Tsao, “Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants,” Human Mutation, vol. 28, no. 6, pp. 578–588, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Garibyan and D. E. Fisher, “How sunlight causes melanoma,” Current Oncology Reports, vol. 12, no. 5, pp. 319–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Raman, T. Sobolik-Delmaire, and A. Richmond, “Chemokines in health and disease,” Experimental Cell Research, vol. 317, no. 5, pp. 575–589, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Raman, P. J. Baugher, Y. M. Thu, and A. Richmond, “Role of chemokines in tumor growth,” Cancer Letters, vol. 256, no. 2, pp. 137–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Maverakis, Y. Miyamura, M. P. Bowen, G. Correa, Y. Ono, and H. Goodarzi, “Light, including ultraviolet,” Journal of Autoimmunity, vol. 34, no. 3, pp. J247–J257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. K. M. Newkirk, F. J. Duncan, E. M. Brannick, H. L. Chandler, A. E. Parent, and D. F. Kusewitt, “The acute cutaneous inflammatory response is attenuated in Slug-knockout mice,” Laboratory Investigation, vol. 88, no. 8, pp. 831–841, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. W. B. Green, P. G. McGuire, K. B. Miska, and D. F. Kusewitt, “Urokinase activity in corneal fibroblasts may be modulated by DNA damage and secreted proteins,” Photochemistry and Photobiology, vol. 73, no. 3, pp. 318–323, 2001. View at Google Scholar · View at Scopus
  12. H. L. Chandler, C. M. H. Colitz, P. Lu, W. J. A. Saville, and D. F. Kusewitt, “The role of the slug transcription factor in cell migration during corneal re-epithelialization in the dog,” Experimental Eye Research, vol. 84, no. 3, pp. 400–411, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Wong, W. D. Anderson, T. Cheng, and K. T. Riabowol, “Monitoring mRNA expression by polymerase chain reaction: the “primer-dropping” method,” Analytical Biochemistry, vol. 223, no. 2, pp. 251–258, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. L. G. Hudson, C. Choi, K. M. Newkirk et al., “Ultraviolet radiation stimulates expression of snail family transcription factors in keratinocytes,” Molecular Carcinogenesis, vol. 46, no. 4, pp. 257–268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Monteagudo, A. Pellín-Carcelén, J. M. Martín, and D. Ramos, “Role of chemokines in melanoma progression,” Actas Dermo-Sifiliograficas, vol. 102, no. 7, pp. 498–504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. S. Payne and L. A. Cornelius, “The role of chemokines in melanoma tumor growth and metastasis,” Journal of Investigative Dermatology, vol. 118, no. 6, pp. 915–922, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. J. E. Rundhaug and S. M. Fischer, “Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis,” Photochemistry and Photobiology, vol. 84, no. 2, pp. 322–329, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Dobos, I. Kenessey, J. Tímár, and A. Ladányi, “Glucocorticoid receptor expression and antiproliferative effect of dexamethasone on human melanoma cells,” Pathology and Oncology Research, vol. 17, no. 3, pp. 729–734, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. H. J. Lee, B. Wall, and S. Chen, “G-protein-coupled receptors and melanoma,” Pigment Cell and Melanoma Research, vol. 21, no. 4, pp. 415–428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Poser and A. K. Bosserhoff, “Transcription factors involved in development and progression of malignant melanoma,” Histology and Histopathology, vol. 19, no. 1, pp. 173–188, 2004. View at Google Scholar · View at Scopus
  21. D. Ilkovitch and D. M. Lopez, “Immune modulation by melanoma-derived factors,” Experimental Dermatology, vol. 17, no. 12, pp. 977–985, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. H. Shirley, V. R. Greene, L. M. Duncan, C. A. T. Cabala, and E. A. Grimm, “Slug expression during melanoma progression,” American Journal of Pathology, vol. 180, no. 6, pp. 2479–2489, 2012. View at Google Scholar
  23. B. Moser and P. Loetscher, “Lymphocyte traffic control by chemokines,” Nature Immunology, vol. 2, no. 2, pp. 123–128, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. C. H. Kim, “Chemokine-chemokine receptor network in immune cell trafficking,” Current Drug Targets, vol. 4, no. 4, pp. 343–361, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. D. S. B. Hoon, M. Banez, E. Okun, D. L. Morton, and R. F. Irie, “Modulation of human melanoma cells by interleukin-4 and in combination with γ-interferon or α-tumor necrosis factor,” Cancer Research, vol. 51, no. 8, pp. 2002–2008, 1991. View at Google Scholar · View at Scopus
  26. S. Pasquali and S. Mocellin, “The anticancer face of interferon alpha (IFN-alpha): from biology to clinical results, with a focus on melanoma,” Current Medicinal Chemistry, vol. 17, no. 29, pp. 33270–3336, 2010. View at Google Scholar · View at Scopus
  27. R. Halaban, “The regulation of normal melanocyte proliferation,” Pigment Cell Research, vol. 13, no. 1, pp. 4–14, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Krasagakis, C. Garbe, C. C. Zouboulis, and C. E. Orfanos, “Growth control of melanoma cells and melanocytes by cytokines,” Recent Results in Cancer Research, vol. 139, pp. 169–182, 1995. View at Google Scholar · View at Scopus
  29. K. Suzuki and T. Hayashi, “Protein C and its inhibitor in malignancy,” Seminars in Thrombosis and Hemostasis, vol. 33, no. 7, pp. 667–672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. G. L. Scheffer, M. J. Flens, S. Hageman, M. A. Izquierdo, R. H. Shoemaker, and R. J. Scheper, “Expression of the vascular endothelial cell protein C receptor in epithelial tumour cells,” European Journal of Cancer, vol. 38, no. 11, pp. 1535–1542, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Munoz, M. Rosso, M. J. Robles-Frias et al., “The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines,” Laboratory Investigation, vol. 90, no. 8, pp. 1259–1269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. E. L. Tan, S. C. Wong, S. K. E. Gan, S. Xu, and K. P. Lam, “The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes,” Journal of Biological Chemistry, vol. 276, no. 23, pp. 20055–20063, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. C. C. Wei, Y. H. Hsu, H. H. Li et al., “IL-20: biological functions and clinical implications,” Journal of Biomedical Science, vol. 13, no. 5, pp. 601–612, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Sabat, E. Wallace, S. Endesfelder, and K. Wolk, “IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases,” Expert Opinion on Therapeutic Targets, vol. 11, no. 5, pp. 601–612, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. G. F. Sonnenberg, L. A. Fouser, and D. Artis, “Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces,” Advances in Immunology, vol. 107, pp. 1–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. D. F. Kusewitt, C. Choi, K. M. Newkirk et al., “Slug/Snai2 is a downstream mediator of epidermal growth factor receptor-stimulated reepithelialization,” Journal of Investigative Dermatology, vol. 129, no. 2, pp. 491–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Matsumura and H. N. Ananthaswamy, “Toxic effects of ultraviolet radiation on the skin,” Toxicology and Applied Pharmacology, vol. 195, no. 3, pp. 298–308, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Tam and K. Stepien, “Secretion of proinflammatory cytokines by normal human melanocytes in response to lipopolysaccharide,” Acta Biochimica Polonica, vol. 58, no. 4, pp. 507–511, 2011. View at Google Scholar
  39. N. Yu, S. Zhang, F. Zuo, K. Kang, M. Guan, and L. Xiang, “Cultured human melanocytes express functional Toll-like receptors 2–4, 7 and 9,” Journal of Dermatological Science, vol. 56, no. 2, pp. 113–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Hong, A. L. Puaux, C. Huang et al., “Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control,” Cancer Research, vol. 71, no. 22, pp. 6997–7009, 2011. View at Google Scholar
  41. P. B. Gupta, C. Kuperwasser, J. P. Brunet et al., “The melanocyte differentiation program predisposes to metastasis after neoplastic transformation,” Nature Genetics, vol. 37, no. 10, pp. 1047–1054, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. B. E. Rich, “IL-20: a new target for the treatment of inflammatory skin disease,” Expert Opinion on Therapeutic Targets, vol. 7, no. 2, pp. 165–174, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Mantovani, “Molecular pathways linking inflammation and cancer,” Current Molecular Medicine, vol. 10, no. 4, pp. 369–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. R. S. Bhatt, J. Merchan, R. Parker et al., “A phase 2 pilot trial of low-dose, continuous infusion, or “metronomic” paclitaxel and oral celecoxib in patients with metastatic melanoma,” Cancer, vol. 116, no. 7, pp. 1751–1756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. L. C. M. Chiu, K. F. Tong, and V. E. C. Ooi, “Cytostatic and cytotoxic effects of cyclooxygenase inhibitors and their synergy with docosahexaenoic acid on the growth of human skin melanoma A-375 cells,” Biomedicine and Pharmacotherapy, vol. 59, supplement 2, pp. S293–S297, 2005. View at Publisher · View at Google Scholar · View at Scopus